This study is currently not recruiting participants.

SURFACE-ENHANCED RAMAN SPECTROSCOPY NANOSENSORS FOR ULTRASENSITIVE CHARACTERIZATION OF DRUGS IN POSTMORTEM TOXICOLOGY

  • STATUS
    Not Recruiting
Updated on 19 February 2024

Summary

Postmortem toxicology was selected to demonstrate the feasibility of our Raman technology because most samples contain larger number of metabolites (decompose drugs in human systems) and demonstrate very high risk of matrix effects (blood coagulation in cadaver) that could provide false analysis data and inaccurate identification of drugs that cause the death.

Description

Postmortem toxicology was selected to demonstrate the feasibility of our Raman technology because most samples contain larger number of metabolites (decompose drugs in human systems) and demonstrate very high risk of matrix effects (blood coagulation in cadaver) that could provide false analysis data and inaccurate identification of drugs that cause the death.

Details
Condition drug overdose
Age 100years or below
Clinical Study IdentifierTX9413
Last Modified on19 February 2024

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.